EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection

Runcong Zhang, Jing Fan, Lu Han iD, Juehui Mao, Liang Sun, Yuetian Yu, Weibin Fan, Jiao Xie, Bin Lin iD, Nengming Lin

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s479561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Runcong Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Changxing People's Hospital, Changxing, People's Republic of China. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19 Drug Treatment, Ritonavir. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCOVID-19 Drug TreatmentRitonavirAdultAgedFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralChinaCOVID-19Dose-Response Relationship, DrugDrug CombinationsEast Asian PeopleModels, BiologicalMonte Carlo Method

Stichwörter der Autor:innen

COVID-19dosing regimennirmatrelvirpopulation pharmacokineticssimulations

Substanzen

Antiviral AgentsDrug CombinationsRitonavir

Autor:innen und Institutionen

  • Department of Pharmacy, Changxing People's Hospital, Changxing, People's Republic of China.
  • Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou, Changxing, People's Republic of China.
  • School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, People's Republic of China.
  • Department of Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

ORCID-Profile: Lu Han, Bin Lin

Zitieren

APA

Zhang, R., Fan, J., Han, L., Mao, J., Sun, L., Yu, Y., Fan, W., Xie, J., Lin, B., & Lin, N. (2024). Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s479561

Vancouver

Zhang R, Fan J, Han L, Mao J, Sun L, Yu Y, et al. Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s479561

BibTeX
@article{Zhang2024,
  author = {Zhang, Runcong and Fan, Jing and Han, Lu and Mao, Juehui and Sun, Liang and Yu, Yuetian and Fan, Weibin and Xie, Jiao and Lin, Bin and Lin, Nengming},
  title = {Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s479561}
}
Kostenlos starten →